Akoustis Technologies, Inc. (AKTSQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Inactive · Last trade price on Jan 2, 2026
Akoustis Technologies Employees
Akoustis Technologies had 117 employees as of June 30, 2024. The number of employees decreased by 105 or -47.30% compared to the previous year.
Employees
117
Change (1Y)
-105
Growth (1Y)
-47.30%
Revenue / Employee
$251,359
Profits / Employee
-$1,318,299
Market Cap
155.00
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 117 | -105 | -47.30% |
| Jun 30, 2023 | 222 | 13 | 6.22% |
| Jun 30, 2022 | 209 | 38 | 22.22% |
| Jun 30, 2021 | 171 | 69 | 67.65% |
| Jun 30, 2020 | 102 | 12 | 13.33% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Akoustis Technologies News
- 4 days ago - Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 days ago - U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO - Seeking Alpha
- 7 days ago - Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets - Business Wire
- 8 days ago - Aktis Oncology prices upsized US IPO at $18 per share - Reuters
- 8 days ago - Aktis Oncology Announces Pricing of its Upsized Initial Public Offering - GlobeNewsWire
- 10 days ago - Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies - Seeking Alpha
- 14 days ago - U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week - Seeking Alpha
- 8 months ago - Akoustis Successfully Completes Sale of Assets to SpaceX - Business Wire